You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API diltiazem hydrochloride extended-release tablets


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing diltiazem hydrochloride extended-release tablets

Detailed excipient profiles for diltiazem hydrochloride extended-release tablets

Excipient focus: CARNAUBA WAX

diltiazem hydrochloride extended-release tablets drug variants containing CARNAUBA WAX

Excipient focus: CELLULOSE, MICROCRYSTALLINE

diltiazem hydrochloride extended-release tablets drug variants containing CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

diltiazem hydrochloride extended-release tablets drug variants containing CROSCARMELLOSE SODIUM

Excipient focus: ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER

diltiazem hydrochloride extended-release tablets drug variants containing ETHYL ACRYLATE AND METHYL METHACRYLATE COPOLYMER

Excipient focus: HYPROMELLOSE

diltiazem hydrochloride extended-release tablets drug variants containing HYPROMELLOSE

Excipient focus: MAGNESIUM STEARATE

diltiazem hydrochloride extended-release tablets drug variants containing MAGNESIUM STEARATE

Excipient focus: MICROCRYSTALLINE WAX

diltiazem hydrochloride extended-release tablets drug variants containing MICROCRYSTALLINE WAX

Excipient focus: POLYDEXTROSE

diltiazem hydrochloride extended-release tablets drug variants containing POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

diltiazem hydrochloride extended-release tablets drug variants containing POLYETHYLENE GLYCOL

Excipient focus: POLYSORBATE 80

diltiazem hydrochloride extended-release tablets drug variants containing POLYSORBATE 80

Excipient focus: POVIDONE

diltiazem hydrochloride extended-release tablets drug variants containing POVIDONE

Excipient focus: SILICON DIOXIDE

diltiazem hydrochloride extended-release tablets drug variants containing SILICON DIOXIDE

Excipient focus: SUCROSE STEARATE

diltiazem hydrochloride extended-release tablets drug variants containing SUCROSE STEARATE

Excipient focus: TALC

diltiazem hydrochloride extended-release tablets drug variants containing TALC

Excipient focus: TITANIUM DIOXIDE

diltiazem hydrochloride extended-release tablets drug variants containing TITANIUM DIOXIDE

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.